Will Pfizer cut its sales force again, by nearly one third? Bloomberg reports that Pfizer may eliminate nearly one-third of its sales force. The plan, which is apparently under consideration by senior …
Pharma News 10_03
Is Eli Lilly the "mystery suitor" for ImClone? - Eli Lilly & Co. is in advanced talks to buy cancer-drug developer ImClone Systems for $70 a share, or $6.1 billion, The Wall Street Journal …
Pharma News 10_19
The Good Stuff: BMS gets approval for new oncology drug (for breast cancer) Ixempra. Merck gets new HIV drug (Isentress) approved in the U.S. And, their Januvia diabetes drug gets new uses …